Cooperative epigenetic modulation by cancer amplicon genesChronic active B-cell-receptor signalling in diffuse large B-cell lymphomaMolecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysA cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor scoreThe serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunityOncogenically active MYD88 mutations in human lymphomaAutologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter studyAngioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4.Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis.Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodIgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin'sGene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterationsThe role of thymomas in the development of myasthenia gravis.Differential diagnosis of laryngeal spindle cell carcinoma and inflammatory myofibroblastic tumor--report of two cases with similar morphology.Chromosomal gains at 9q characterize enteropathy-type T-cell lymphomaClinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.Thymoma and thymic carcinoma: an update of the WHO Classification 2004.Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.Pathomechanisms of paraneoplastic myasthenia gravis.'Normal counterparts' of nodal peripheral T-cell lymphoma.Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomasGenomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma.Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.State-of-the-art classification and multimodality treatment of malignant thymoma.Proficient mismatch repair protein expression in Hodgkin and Reed Sternberg cells.Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin lymphoma classification project.Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project.Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project.Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification.Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas - Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c.Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival.Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats.
P50
Q24608701-C0C66317-DAE5-4A67-9503-944556349C87Q24613755-138CB1C8-FCB5-4CC0-969B-4F1BEF09DFC8Q24652565-AF140BBC-DAC1-4DAE-A86B-11F0681AD0F6Q24653343-23173B94-7236-40F3-AF17-06D66CBE378FQ28198462-3EEF2391-4BE8-4AC2-A397-7DB550303B74Q28301648-00F4BC1D-CBE1-47E4-88E9-E2DB34347193Q28301671-30776A3B-577C-4074-A18B-3D7AACB47B4BQ31119483-7ED548F8-447E-4372-9E93-F1A6FD5F724BQ31152796-B9FF2B1C-DA1F-4C9C-A23B-26B6B941FA30Q33225554-DB0973ED-FF69-4E04-9865-09B13EC05E96Q33300320-EDC1AC29-8548-481B-8835-7B6BAB95A4D7Q33349465-4E735026-5DC3-4E6E-BF19-6F6FC80C1C26Q34099059-C62013E0-2211-4A84-868B-13C28B42971BQ34479078-0F0FE895-710C-4D70-BC4B-5FE7D225E3BEQ34580808-42F422AF-F80E-4D97-BC2B-9C619E502EACQ35098010-DE3C8AF5-A174-43D9-897F-79307920D274Q35573383-30614CEE-075E-4300-8B3C-1CD66AEE808FQ35605292-E2B72C3B-6F5F-48F2-A52A-DEA308FDF0A5Q35747806-85B0CCF7-AEAC-4270-8F11-6DE0AAE19D79Q36188591-9993DE71-00DD-4C20-B952-A7B5281EE6F8Q36263151-B8A89377-65B2-476C-8054-2B9A5DB7CD71Q36267192-9AF12E0A-C488-4FB6-870F-D1F1B6F3D468Q36502022-D406593B-7DB7-45EB-A153-0012359F0F7DQ36511027-6622E18B-33D8-4A19-ACC6-FAB044A53CFFQ36721503-A8FF7F21-6795-4396-8D46-4975A093442DQ37266079-74A63437-6096-4C26-A6CC-CD33D72C98FCQ37269010-FD8B76CE-37E2-4B43-B0F6-8C9F0F17DA85Q37304125-8526A8FF-F9DF-4309-BDF5-B9C77BD15EF6Q37975734-5726A3BE-5F2F-42EF-B33D-2B1577B59D86Q38293314-1293CFD6-872A-43A7-BD2E-77142B5A7962Q38554985-3C0AF5BD-8E9C-4783-8A70-1305305B21B4Q38625454-3BD6135C-B3E3-425B-A64C-B8522DB5AD63Q38674038-CCF945E5-A6C1-4C41-AD3C-E5DC2A27D3DCQ38742496-D7DF4EAF-7BD3-4BE4-A8D6-E67862ED4373Q38781630-222523F7-EC38-4E4D-8D48-987480B600C5Q38916754-77507C40-AD7C-4618-86B6-BB565BBBBFFDQ39034212-84AD2953-5B6E-46FF-9831-BE44D00919AFQ40005246-D309EE84-640D-4EDA-AE92-FE3E6FF3F305Q40227240-049822B4-F011-4037-8CA8-ADE1E70E3FB4Q40256160-3B06D7A0-2F83-4213-A116-831B940FB2BC
P50
description
Duits patholoog
@nl
German pathologist and university teacher
@en
deutscher Emeritus für Pathologie
@de
tysk professor
@da
tysk professor
@sv
name
Hans Konrad Müller-Hermelink
@ast
Hans Konrad Müller-Hermelink
@ca
Hans Konrad Müller-Hermelink
@da
Hans Konrad Müller-Hermelink
@de
Hans Konrad Müller-Hermelink
@en
Hans Konrad Müller-Hermelink
@es
Hans Konrad Müller-Hermelink
@fr
Hans Konrad Müller-Hermelink
@nds
Hans Konrad Müller-Hermelink
@nl
Hans Konrad Müller-Hermelink
@pt
type
label
Hans Konrad Müller-Hermelink
@ast
Hans Konrad Müller-Hermelink
@ca
Hans Konrad Müller-Hermelink
@da
Hans Konrad Müller-Hermelink
@de
Hans Konrad Müller-Hermelink
@en
Hans Konrad Müller-Hermelink
@es
Hans Konrad Müller-Hermelink
@fr
Hans Konrad Müller-Hermelink
@nds
Hans Konrad Müller-Hermelink
@nl
Hans Konrad Müller-Hermelink
@pt
prefLabel
Hans Konrad Müller-Hermelink
@ast
Hans Konrad Müller-Hermelink
@ca
Hans Konrad Müller-Hermelink
@da
Hans Konrad Müller-Hermelink
@de
Hans Konrad Müller-Hermelink
@en
Hans Konrad Müller-Hermelink
@es
Hans Konrad Müller-Hermelink
@fr
Hans Konrad Müller-Hermelink
@nds
Hans Konrad Müller-Hermelink
@nl
Hans Konrad Müller-Hermelink
@pt
P1006
P1015
P214
P227
P244
P268
P269
P1006
P1015
P1207
n2007108919
P1412
P1559
Hans Konrad Müller-Hermelink
@de
P19
P21
P213
0000 0001 1933 1430